In vitro and in vivo anti-Helicobacter pylori activity of Y-904, a new fluoroquinolone
スポンサーリンク
概要
- 論文の詳細を見る
- 2003-06-01
著者
-
Hirayama Fumihiro
Research Laboratories Yoshitomi Pharmaceutical Industries
-
Yamamoto Katsuhiro
Pharmaceuticals Research Unit Research & Development Division Mitsubishi Pharma Corporation
-
Yokoyama Yoshito
Research Laboratories Yoshitomi Pharmaceutical Industries
-
Haga Keiichiro
Pharmaceutical Research Division Yoshitomi Pharmaceutical Industries
-
Iwao Eiji
Research Laboratories Yoshitomi Pharmaceutical Industries
-
IWAO Eiji
Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Pharma Corporation
-
YOKOYAMA Yoshito
Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Pharma Corporation
-
HIRAYAMA Fumihiro
Pharmaceuticals Research Unit, Research & Development Division, Mitsubishi Pharma Corporation
-
Kusuhara Hidenobu
Pharmaceutical Research Division Yoshitomi Pharmaceutical Industries
関連論文
- Virulence factors of Helicobacter pylori affecting its gastric colonization in Mongolian gerbils
- Evaluation of combined antibiotic-omeprazole therapies in Helicobacter pylori-infected Mongolian gerbils
- Induction of gastric ulcer and intestinal metaplasia in Mongolian gerbils infected with Helicobacter pylori
- Potent antibacterial activity of Y-754, a novel benzimidazole compound with selective action against Helicobacter pylori
- In vitro and in vivo anti-Helicobacter pylori activity of Y-904, a new fluoroquinolone
- Development of poorly differentiated adenocarcinoma and carcinoid due to long-term Helicobacter pylori colonization in Mongolian gerbils